Follow-Up Data of Safusidenib in Patients With IDH-Mutant Gliomas by Madaline Spencer| Published on: Aug 14, 2026

Follow-Up Data of Safusidenib in Patients With IDH-Mutant Gliomas by Madaline Spencer| Published on: Aug 14, 2026 Alexandra Miller, MD, PhD, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at the Perlmutter Cancer Center at NYU Langone Health, discusses follow-up data on the safety and efficacy of safusidenib in patients with IDH-mutant gliomas. https://checkrare.com/follow-up-data-of-safusidenib-in-patients-with-idh-mutant-gliomas/